Last reviewed · How we verify
Intra articular injection with Ropivacaine — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Intra articular injection with Ropivacaine (Intra articular injection with Ropivacaine) — Mayo Clinic.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intra articular injection with Ropivacaine TARGET | Intra articular injection with Ropivacaine | Mayo Clinic | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intra articular injection with Ropivacaine CI watch — RSS
- Intra articular injection with Ropivacaine CI watch — Atom
- Intra articular injection with Ropivacaine CI watch — JSON
- Intra articular injection with Ropivacaine alone — RSS
Cite this brief
Drug Landscape (2026). Intra articular injection with Ropivacaine — Competitive Intelligence Brief. https://druglandscape.com/ci/intra-articular-injection-with-ropivacaine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab